We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Information for those who have been prescribed Paxlovid.
This collection brings together all documents relating to BIS research papers.
Sets out legal text on the manufacture, authorisation, marketing, distribution and post-authorisation surveillance of veterinary medicines.
The publication scheme specifies the categories of information that DBT publishes and how to access that information.
The CMA investigated alleged excessive and unfair pricing, anti-competitive agreements and abusive conduct with respect to hydrocortisone tablets under Chapters I and II CA98 and Articles 101 and 102 TFEU.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Types of model articles of association a limited company can have, including older versions of Table A from previous company legislation.
Check the tariff classification for articles and equipment for general physical exercise and other sports or outdoor games.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Proposed updates to the lists of standards for businesses.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Get help to classify various items of iron and steel, primarily those classified under chapter 72.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Information about COVID-19 and pregnancy from the Royal College of Obstretricians and Gynaecologists (RCOG).
Keep up to date with the latest information from the UK GLP monitoring authority.
This series brings together all documents relating to Joint Doctrine Publication (JDP)
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.